A Dexamethasone Prodrug Reduces the Renal Macrophage Response and Provides Enhanced Resolution of Established Murine Lupus Nephritis
Open Access
- 28 November 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (11) , e81483
Abstract
We evaluated the ability of a macromolecular prodrug of dexamethasone (P-Dex) to treat lupus nephritis in (NZB × NZW)F1 mice. We also explored the mechanism underlying the anti-inflammatory effects of this prodrug. P-Dex eliminated albuminuria in most (NZB × NZW)F1 mice. Furthermore, P-Dex reduced the incidence of severe nephritis and extended lifespan in these mice. P-Dex treatment also prevented the development of lupus-associated hypertension and vasculitis. Although P-Dex did not reduce serum levels of anti-dsDNA antibodies or glomerular immune complexes, P-Dex reduced macrophage recruitment to the kidney and attenuated tubulointerstitial injury. In contrast to what was observed with free dexamethasone, P-Dex did not induce any deterioration of bone quality. However, P-Dex did lead to reduced peripheral white blood cell counts and adrenal gland atrophy. These results suggest that P-Dex is more effective and less toxic than free dexamethasone for the treatment of lupus nephritis in (NZB × NZW)F1 mice. Furthermore, the data suggest that P-Dex may treat nephritis by attenuating the renal inflammatory response to immune complexes, leading to decreased immune cell infiltration and diminished renal inflammation and injury.Keywords
This publication has 31 references indexed in Scilit:
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisArthritis Care & Research, 2012
- Neutrophil gelatinase–associated lipocalin is instrumental in the pathogenesis of antibody‐mediated nephritis in miceArthritis & Rheumatism, 2011
- Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarringArthritis Care & Research, 2011
- The Ngal reporter mouse detects the response of the kidney to injury in real timeNature Medicine, 2011
- Lipocalin 2 is essential for chronic kidney disease progression in mice and humansJournal of Clinical Investigation, 2010
- Effects of glucocorticoid treatment on bone strengthJournal of Bone and Mineral Metabolism, 2010
- Young Investigator Award Lecture of the APS Water and Electrolyte Homeostasis Section, 2008: The pathophysiology of hypertension in systemic lupus erythematosusAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Synthesis and Evaluation of a Well-defined HPMA Copolymer–Dexamethasone Conjugate for Effective Treatment of Rheumatoid ArthritisPharmaceutical Research, 2008
- Renal interstitial cells, proteinuria and progression of lupus nephritis: new frontiers for old factorsLupus, 2008
- Composition of immune deposits present in glomeruli of NZB/W F1 miceClinical Immunology and Immunopathology, 1991